The mutation leading to the loss of this cleavage site actually stops APC from effectively inactivating both Factor Va and Factor VIIIa.
A mutación que orixina a perda deste sitio de clivaxe impide que a APC inactive eficazmente tanto o factor Va coma o factor VIIIa.